Osteoporosis
AI in osteoporosis – Fract or Fiction
Explore the transformative role of artificial intelligence in modern osteoporosis care. Presentation by Dr Nicholas Fuggle, delves into how cutting-edge AI tools — including advanced neural networks and computer vision — are revolutionising fracture risk assessment and bone mineral density screening.
The presentation will showcase real-world applications across diagnostic imaging, omic data interpretation, and the integration of chatbots and large language models within clinical workflows. You will gain a comprehensive, evidence-based understanding of how AI is enhancing precision, efficiency, and patient outcomes in bone health management.
You will learn:
- An understanding of structure and function of neural networks
- To evaluate the role of neural networks in osteoporosis diagnosis and risk prediction
- A comprehension of the fundamentals of computer vision
- An understanding of the application of computer vision in opportunistic bone mineral density screening
- To assess the use of chatbots and large language models in osteoporosis education and communication.
Dr Nicholas Fuggle
Associate Professor in Rheumatology
MRC Lifecourse Epidemiology Centre
University of Southampton
United Kingdom
Nick Fuggle is an Associate Professor at the MRC Lifecourse Epidemiology Centre (MRC LEC), University of Southampton and an Honorary Consultant Rheumatologist at University Hospitals Southampton. He completed his PhD, which was funded by a Doctoral Research Fellowship from the Dunhill Medical Trust, under the supervision of Professors Cyrus Cooper and Elaine Dennison. He investigated epigenetic biomarkers of ageing and their ability to predict musculoskeletal phenotypes. He continues his research in musculoskeletal ageing with a focus on the deployment of computer vision on imaging modalities to predict musculoskeletal outcomes. He has held a Turing Fellowship at the Alan Turing Institute and is a co-organiser of the Clinical AI Interest Group. He has received numerous national and international awards including the British Society of Rheumatology Young Investigator Award (2022) and the International Osteoporosis Foundation Pierre Meunier Award (2022). He is on the Editorial Board of Osteoporosis International, Calcified Tissues International and Ageing Clinical and Experimental Research. He sits of the board of the European Society for the Clinical and Economic aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Disorders (ESCEO).
